Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
As Covid 19 manifestations that have been recently described, inflammatory manifestation have major impact in infectious disease lesions. Some of them are delayed and provide Post infectious inflammatory reaction (PIIR), they are challenging for diagnosis and for management. Clinician have to avoid unnecessary antibiotic thearapy and in if necessary have to give immunosuppressive therapy. Except for rheumatic disease for group A streptococcus (GAS) infections there are not stanrdized diagnostic criteria and therapeutic protocol, and PIIR have probably a suboptimal management. In this context the investigators aim to explore PIIR in the 3 most frequent bacterial invasive infection in France, by a retrospective monocentric study. The investigators include all children betwwen 2012 and 2018 hospitalized for infections by Streptococcus pneumoniae (SP), Neisseria meningitidis (NM), and GAS invasive infections.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Describe the frequency PIIRs | Describe the frequency PIIRs following invasive pneumococcal, meningococcal, or group A Streptococcal infection | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Characteristics PIIRs following invasive pneumococcal, meningococcal, or group A Streptococcal infection | Describe the characteristics PIIRs following invasive pneumococcal, meningococcal, or group A Streptococcal infection | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Predictors of PIIRs | Identified the predictors of PIIRs in order to find warning symptoms | 1 day |
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Pediatric population
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eric JEZIORSKI | Contact | 04 67 33 57 98 | 33 | e-jeziorski@chu-montpellier.fr |
| Name | Affiliation | Role |
|---|---|---|
| Eric JEZIORSKI | University Hospital, Montpellier | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uhmontpellier | Recruiting | Montpellier | 34295 | France |
NC
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| D013290 | Streptococcal Infections |
| D008585 | Meningitis, Meningococcal |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D016920 | Meningitis, Bacterial |
| D020806 | Central Nervous System Bacterial Infections |
| D008589 | Meningococcal Infections |
| D016870 | Neisseriaceae Infections |
| D016905 | Gram-Negative Bacterial Infections |
| D002494 | Central Nervous System Infections |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D008581 | Meningitis |
| D000090862 | Neuroinflammatory Diseases |
Not provided
Not provided